Discover 471 paid clinical trials in Little Rock, Arkansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 471
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Location: Little Rock AR, Milwaukee WI, Columbus OH, Ann Arbor MI,
Sponsor: Weill Medical College of Cornell University
Sex: All
Age: 0 - 17
Code: NCT06994442
Phase3, Recruiting
Ensuring Access to Optimal Therapy in CF: The ENACT Study
for
Cystic Fibrosis (CF)
Location: Little Rock AR, Birmingham AL, Seattle WA
Sponsor: Arkansas Children's Hospital Research Institute
Sex: All
Age: 3+
Code: NCT07148739
Recruiting
A Study of Bleeding and Treatment in Participants With Von Willebrand Disease
for
Von Willebrand Disease (VWD),
Location: Little Rock AR, Dallas TX, New Orleans LA, Atlanta GA,
Sponsor: Hemab ApS
Sex: All
Age: 16+
Code: NCT06610201
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Little Rock AR, Jackson MS, Tulsa OK, Dallas TX,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 30
Code: NCT04546399
Phase2, Recruiting
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
for
B Acute Lymphoblastic Leukemia
Location: Little Rock AR, Jackson MS, Dallas TX, St Louis MO,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 46
Code: NCT06124157
Phase2, Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
for
Recurrent Langerhans Cell Histiocytosis,
Location: Little Rock AR, Jackson MS, St Louis MO,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 22
Code: NCT05828069
Phase2, Recruiting
Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)
for
Von Willebrand Disease (VWD)
Location: Little Rock AR, Dallas TX, Atlanta GA, Ann Arbor MI,
Sponsor: Vega Therapeutics, Inc
Sex: All
Age: 12 - 70+
Code: NCT07115004
Phase3, Recruiting
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
for
Hematopoietic and Lymphatic System Neoplasm,
Location: Little Rock AR, Memphis TN, Dallas TX, Oklahoma City OK,
Sponsor: Children's Oncology Group
Sex: All
Age: 15 - 20
Code: NCT06410209
Phase2, Recruiting
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
for
Hematologic Malignancies, Inherited Disorders of Metabolism,
Location: Little Rock AR, Memphis TN, Jackson MS, Dallas TX,
Sponsor: Center for International Blood and Marrow Transplant Research
Sex: All
Age: 0+
Code: NCT01351545
Recruiting
Comparison of Uncomplicated Candidemia Therapy Duration in Children
for
Invasive Candidiasis
Location: Little Rock AR, St Louis MO, Dallas TX, Birmingham AL,
Sponsor: Arkansas Children's Hospital Research Institute
Sex: All
Age: 0+
Code: NCT05763251
Recruiting
Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients
for
Hematopoietic Cell Transplant, Solid Organ Transplant,
Location: Little Rock AR, Memphis TN, St Louis MO, Fort Worth TX,
Sponsor: Arkansas Children's Hospital Research Institute
Sex: All
Age: 0 - 18
Code: NCT05550298
Recruiting
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
for
Stage II Nasopharyngeal Carcinoma AJCC v8,
Location: Little Rock AR, Memphis TN, Jackson MS, St Louis MO,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 21
Code: NCT06064097
Phase2, Recruiting
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
for
Failed or Difficult Intubation, Sequela, Intubation; Difficult,
Location: Little Rock AR, Dallas TX, Irving TX, Birmingham AL,
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 0+
Code: NCT02493478
Recruiting
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction